Domestic markets witnessed a modest rebound on Thursday on dip-buying as oil prices eased, despite the recent US–Iran escalation. However, the recovery proved fleeting, weighed down by an increasingly fragile global backdrop. Banking and pharma stocks attracted buying interest, supported by resilient earnings, favourable RBI measures, and a shift toward defensive sectors. In contrast, mid and small caps saw profit booking after their recent outperformance, indicating signs of near-term consolidation.
Here are two stock recommendations for Friday
